In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening Performance

作者: Teresa Kaserer , Martina Höferl , Klara Müller , Sebastian Elmer , Markus Ganzera

DOI: 10.1002/MINF.201400192

关键词:

摘要: The cytochrome P450 (CYP) superfamily represents the major enzyme class responsible for metabolism of exogenous compounds. Investigation clearance pathways is therefore an integral part in early drug development, as any alteration metabolic enzymes may markedly influence toxicological profile and efficacy novel In silico methods are widely applied development to complement experimental approaches. Several different tools available that purpose, however, CYP they have only been retrospectively so far. Within this study, pharmacophore- shape-based models a docking protocol were generated prediction CYP1A2, 2C9, 3A4 inhibition. All theoretically validated models, workflow, additional external bioactivity profiling independently parallel predict inhibition 29 compounds from synthetic natural origin. After subsequent assessment predictions, we analyzed compared prospective performance all methods, thereby defining suitability techniques enzymes. We observed quite substantial differences performances tools, suggesting rational selection virtual screening method proved perform best can largely improve success rates when it comes prediction.

参考文章(91)
Jason K. Yano, Michael R. Wester, Guillaume A. Schoch, Keith J. Griffin, C. David Stout, Eric F. Johnson, The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. Journal of Biological Chemistry. ,vol. 279, pp. 38091- 38094 ,(2004) , 10.1074/JBC.C400293200
Eric F. Johnson, C. David Stout, Structural Diversity of Eukaryotic Membrane Cytochrome P450s Journal of Biological Chemistry. ,vol. 288, pp. 17082- 17090 ,(2013) , 10.1074/JBC.R113.452805
Stefaan Sansen, Jason K. Yano, Rosamund L. Reynald, Guillaume A. Schoch, Keith J. Griffin, C. David Stout, Eric F. Johnson, Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. Journal of Biological Chemistry. ,vol. 282, pp. 14348- 14355 ,(2007) , 10.1074/JBC.M611692200
Charity D. Scripture, John A. Pieper, Clinical Pharmacokinetics of Fluvastatin Clinical Pharmacokinectics. ,vol. 40, pp. 263- 281 ,(2001) , 10.2165/00003088-200140040-00003
Paul C. D. Hawkins, A. Geoffrey Skillman, Anthony Nicholls, Comparison of Shape-Matching and Docking as Virtual Screening Tools Journal of Medicinal Chemistry. ,vol. 50, pp. 74- 82 ,(2007) , 10.1021/JM0603365
Kelly L. Damm-Ganamet, Richard D. Smith, James B. Dunbar, Jeanne A. Stuckey, Heather A. Carlson, CSAR Benchmark Exercise 2011–2012: Evaluation of Results from Docking and Relative Ranking of Blinded Congeneric Series Journal of Chemical Information and Modeling. ,vol. 53, pp. 1853- 1870 ,(2013) , 10.1021/CI400025F
Tomas Vanek, Daniela Schuster, Veronika Temml, Teresa Kaserer, Zsofia Kutil, Premysl Landa, Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio Future Medicinal Chemistry. ,vol. 6, pp. 1869- 1881 ,(2014) , 10.4155/FMC.14.114
Charles W. Locuson, Peter M. Gannett, Robyn Ayscue, Timothy S. Tracy, Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9. Journal of Medicinal Chemistry. ,vol. 50, pp. 1158- 1165 ,(2007) , 10.1021/JM060706P
John Arrowsmith, A decade of change Nature Reviews Drug Discovery. ,vol. 11, pp. 17- 18 ,(2012) , 10.1038/NRD3630
C. G. Wermuth, C. R. Ganellin, P. Lindberg, L. A. Mitscher, Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) Pure and Applied Chemistry. ,vol. 70, pp. 1129- 1143 ,(1998) , 10.1351/PAC199870051129